Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mark Myerson

Orthopaedic Surgery Baltimore, MD Medical Doctor

NPI 1386687812 CMS profile 198346

301 Saint Paul Pl, Main Floor, Baltimore, MD 21202

Open in the dashboard

General payments

$10,511,718

434 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$11,604,557

5 holdings reported · through program year 2025

Research they led as principal investigator

$4,855 paid to institutions, not to them · program year 2023

Through program year 2025, Mark Myerson of Baltimore, MD is reported in the CMS Open Payments database as having received $10,511,718 across 434 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $4,855 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $11,604,557 across 5 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $77,092 47
2024 General $228,888 40
2023 General $377,276 51
2022 General $429,259 65
2021 General $428,493 68
2020 General $8,514,545 58
2019 General $456,166 105
2021 Ownership $26,182 1
2020 Ownership $1,663,736 2
2019 Ownership $9,914,639 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mark Myerson
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Mark Myerson were reported at $77,092. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Mark Myerson Orthopaedic Surgery median Middle half National median
2019 $456,166 $644 $140–$2,844 $163
2020 $8,514,545 $312 $75–$1,860 $114
2021 $428,493 $520 $117–$2,495 $132
2022 $429,259 $598 $128–$2,731 $149
2023 $377,276 $461 $128–$2,264 $160
2024 $228,888 $497 $134–$2,475 $164
2025 $77,092 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Paragon 28, Inc. $9,773,541 294 payments
  2. DePuy Synthes Products, Inc. $569,816 35 payments
  3. Integra LifeSciences Corporation $78,286 17 payments
  4. Smith+Nephew, Inc. $39,392 22 payments
  5. Wright Medical Technology, Inc. $22,727 17 payments
  6. International Life Sciences $10,996 4 payments
  7. Stryker Corporation $6,143 21 payments
  8. Bone Support Inc. $5,000 1 payment
  9. Zimmer Biomet Holdings, Inc. $4,322 20 payments
  10. Turner Imaging Systems, Inc. $1,234 1 payment
  11. Other $260 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Current or prospective ownership or investment interest $8,250,000 1 payment
  2. Consulting Fee $1,043,151 31 payments
  3. Royalty or License $1,028,579 180 payments
  4. Charitable Contribution $95,192 10 payments
  5. Travel and Lodging $50,136 78 payments
  6. Grant $27,674 3 payments
  7. Food and Beverage $14,034 130 payments
  8. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,952 1 payment
Products named General payments · program years 2019–2025
  1. Product Portfolio $571,591 63 payments
  2. PORTFOLIO $536,285 84 payments
  3. SALTO TALARIS TOTAL ANKLE PROSTHESIS Recon-Lower Extremity $71,447 15 payments
  4. Hammerlock $34,253 3 payments
  5. Integra XT $26,421 15 payments
  6. MAX LOCK $19,265 4 payments
  7. FLEXBAND $9,962 2 payments
  8. XT Revision $8,603 3 payments
  9. SALTO TALARIS TOTAL ANKLE PROSTHESIS Recon-Lower Extremity $6,839 2 payments
  10. CERAMENTBONE VOID FILLER $5,000 1 payment
  11. Other $33,720 116 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

434 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record